Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Learn what customers are saying about no annual fee travel credit cards. Gain insights to help you choose the right card for your travels.
22,814 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Arm Holdings has ridden a scorching AI-fueled rally in 2026, but today’s roughly 10% slide raises questions about mom...
A looming health crisis tied to screen use could spike future medical bills as millions of young Americans age into a...
A field-wide quantum ETF costs 0.40% and promises diversified exposure to IonQ and peers, challenging single-stock be...
A six-year Wharton study links leader narcissism to resistance to remote work. The research suggests Fortune 500 boss...
The GRID fund has surged about 23% in 2026, outpacing the traditional utilities ETF XLU as AI-enabled grid modernizat...
More than half of U.S. adults lack essential estate planning documents, a trend that persists despite rising financia...
When the Fed paused, a 72-year-old retired investor moved money from stocks to Treasuries for stability. The plan loo...
Tanger Outlets, a leading retail REIT, reports a rebound in shopper traffic and demand across its outlet centers in e...
A new poll in 2026 finds a rising minority of Gen Z workers would prefer a robot supervisor, challenging traditional ...
South Korea’s Kiwoom Securities is nearing a deal to take a minority stake in Bithumb, signaling growing institutiona...
Address Realty has tapped Eddie Sturgeon to lead growth, signaling a bold push to expand across the U.S. and deepen t...